ABSTRACT
This study aims at determining whether there was an association among anxiety, depression and allergic illnesses. It suggests the proper therapeutic treatment. During a year, our research work team worked with a group of 82 female and male patients (from 13 to 76 years old) who suffered from various types of allergies. Two psychometric scales were used to carry out this study: Hamiltons scale for anxiety whereas Beck Depression Inventory (BDI-II) and Zungs for depression. The association and its percentage were analyzed in patients who reported typical symptoms during their first check-up. They were free of psychopharmacologic drugs and psychotherapies. The presence of anxiety and depression was interpreted as another factor in the development of allergic symptoms. The following results were achieved as regards: for anxiety, an association positive 95
. For depression, the results showed that there was a positive tendency for the association with an allergic illness. The conclusions showed that there is a positive association between anxiety and allergies. As regards depression and allergic illness, there is only a positive tendency. These final results would raise awareness of how to deal with anxiety and depression in allergic patients, both psychopharmacologically and psychotherapeutically.
Subject(s)
Anxiety/etiology , Depression/etiology , Hypersensitivity/complications , Adult , Young Adult , Anxiety/epidemiology , Depression/epidemiology , Female , Hypersensitivity/epidemiology , Humans , Aged , Male , Middle AgedABSTRACT
La preeclampsia-eclampsia se complica a menudo con alteraciones cerebrovasculares. Las manifestaciones clínicas son variables y el vasoespasmo es un problema habitual. Se presenta edema, trombosis, hemorragias, cambios fibrinoides transmurales, se pierde la autorregulación cerebral en las regiones dañadas y los trastornos iónicos transmembrana pueden ser la causa de convulsiones. El tratamiento preventivo de la preeclamsia-eclampsia consiste en el control de la presión arterial y del volumen intravascular, protección de las lesiones edoteliales e interrupción del embarazo. Las medidas específicas incluyen el empleo de glucocorticoides, clacioantagonistas, fenobarbital, flunitrazepan, clonazepan, difenilhidantoína y sulfato de magnesio intravenoso. El seguimiento de la enfermedad se hace mediante la evaluación frecuente del estado físico de la enferma, EEG, tomografía computada y resonancia magnética. Las emergencias quirúrgicas requieren de la presencia de un neurocirujano. En este artículo revisamos la fisiopatología, prevención y tratamiento del daño neurológico debido a la preeclampsia-eclampsia